»» Searching for " LDL "
 Related Search Tags:  AMRN Nasdaq:AMRN Amarin AMR101 Triglycerides Aegerion AEGR Nasdaq:AEGR Lomitapide LDL-C ELX WAIR LDL NYSE:ELX NYSE:WAIR NYSE:LDL
Showing Results 1-3 of 3 |  Sort by:     
Page 1 of 1  |  Go to page   
rnrnWelcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Amarin Corporation plc - symbol AMRN - reported that its New Drug Application for AMR101 has been accepted for filing by the FDA. Amarin is developing AMR101 for the treatment of patients with very high triglyceride levels and as a potentially first-in-class therapy for patients with high triglyceride levels who are also on statin therapy for elevated LDL-cholesterol levels. Triglycerides are a type of fat in the blood. Persons with a high triglyceride level often have other conditions such as diabetes and obesity that also increase the chances of developing heart disease. Amarin Corporation is a late-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekerarn
Amarin (AMRN) FDA...
Categories: Videos 
Added: 178 days ago
By: karmastock
Runtime: 1m27s
Views: 54
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Aegerion Pharmaceuticals Incorporated - AEGR - provided a clinical update on its lomitapide. Aegerion reported that the 78-week data from its pivotal Phase III clinical trial is consistent with data previously reported at the 26- and 56-week time points. According to the company, the data demonstrate that the reduction in LDL-C cholesterol from baseline was maintained at 78-weeks. Aegerion Pharmaceuticals’ Lomitapide is being evaluated for its ability to reduce low density lipoprotein (LDL-C) or bad cholesterol levels in patients with homozygous familial hypercholesterolemia. Aegerion Pharmaceuticals aspires to change the way rare, genetic lipid disorders are treated. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekerarnrn***********rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
Aegerion (AEGR) Clinical...
Categories: Videos 
Added: 135 days ago
By: karmastock
Runtime: 1m12s
Views: 36
 | Comments: 0
Not yet rated
On its second quarter fiscal 2012, Emulex Corp - ELX - posted net revenues of $128.7 million, an increase of 13% year-over-year and 9% sequentially. Wesco Aircraft Holdings Inc - WAIR - reported results for its first quarter fiscal 2012, posting record revenue of $192.6 million, an 11% increase compared to the same period the prior year. Charter Medical Ltd, a subsidiary of Lydall Inc - LDL -, reported that it received CE Mark approval on its next generation Cell Freeze Cryogenic Storage Containers for Hematopoietic Progenitor Cellsrnrn*********************************rnrnTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)rn
(WAIR, ELX, LDL)...
Categories: Videos 
Added: 116 days ago
By: karmastock
Runtime: 1m16s
Views: 45
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.0754 seconds.